HOME
LUPIN FOUNDATION
CAREERS Careers Overview Life at Lupin Campus Connect Learning & Development Current Openings P.L.E.D.G.E.
CONTACT US Contact Us Global Offices Partner With Us Lupin for Suppliers GST Information

FEATURED

2018 ▼
2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

Lupin Announces Litigation Settlement with Schering-Plough Corporation for Desloratadine®

December 17, 2008

Lupin appoints Divakar Kaza as President – Human Resources

December 12, 2008

Lupin Q2 FY 08-09 – Strong Performance & Strategic Growth

October 24, 2008

Lupin in Equity Partnership with Pharma Dynamics, South Africa

September 18, 2008

Lupin Acquires Stake in Generic Health, Australia

August 21, 2008

Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc. for AeroChamber Plus® Brand in the US

August 19, 2008

Lupin receives USFDA approval for Divalproex Sodium Delayed-Release Tablets

July 31, 2008

Lupin Makes an Acquisition in Germany

July 30, 2008

Lupin appoints New NCE Research Head

June 26, 2008

Lupin Enters Into Marketing Alliance with ASCEND Therapeutics for SUPRAX® 400 mg Tablets in the U.S.

June 26, 2008

Lupin receives USFDA approval for Escitalopram Oxalate Tablets

June 16, 2008

Lupin receives USFDA Approval for Topiramate Tablets

May 30, 2008

Lupin FY 2007-08 Consolidated Net Profit up 32% to Rs. 4083 mn

May 14, 2008

Lupin Launches SUPRAX ®400 mg Tablets in the US

April 28, 2008

Lupin Q3 FY0708 Consolidated Net Profit up 192% to Rs. 1809 Mn

January 22, 2008